Ser435
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser435  -  IRF5 (human)

Site Information
EMFSGELsWsADsIR   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 26389900

In vivo Characterization
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling ( 3 ) , mass spectrometry ( 1 ) , mutation of modification site ( 1 , 2 , 3 ) , western blotting ( 1 )
Disease tissue studied:
fibrosarcoma of soft tissue ( 1 )
Relevant cell line - cell type - tissue:
293 (epithelial) ( 1 ) , 2fTGH (fibroblast) ( 3 ) , E.coli (bacterial) ( 2 ) , HT1080 (fibroblast) ( 1 )

Downstream Regulation
Effects of modification on IRF5:
activity, induced ( 2 ) , intracellular localization ( 1 )
Effects of modification on biological processes:
apoptosis, induced ( 1 ) , transcription, induced ( 1 )

References 

1

Chang Foreman HC, Van Scoy S, Cheng TF, Reich NC (2012) Activation of interferon regulatory factor 5 by site specific phosphorylation. PLoS One 7, e33098
22412986   Curated Info

2

Chen W, et al. (2008) Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nat Struct Mol Biol 15, 1213-20
18836453   Curated Info

3

Barnes BJ, Kellum MJ, Field AE, Pitha PM (2002) Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol 22, 5721-40
12138184   Curated Info